Status:
UNKNOWN
Effectiveness of a Cardiovascular Risk Intervention Program in Patients With Schizophrenia (PRISCA)
Lead Sponsor:
Dr. Pere Roura-Poch
Conditions:
Schizophrenia
Cardiovascular Risk Factor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main objective is to determine the effectiveness of a program which consists of multidisciplinary, intensive and individualized interventions, carried out by a group of health professionals (psych...
Eligibility Criteria
Inclusion
- adults (≥18 years of age), outpatient, current diagnostic of schizophrenia, follow-up by mental health network in Catalonia, signed informed consent.
Exclusion
- other severe mental illnesses different from schizophrenia, patients with intellectual disabilities or clinical acute psychotic relapse
Key Trial Info
Start Date :
January 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2021
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04276012
Start Date
January 20 2020
End Date
February 28 2021
Last Update
September 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vic Hospital Consortium
Vic, Catalonia, Spain, 08500